Table 3.
Characteristic | N | Summary ROR (95 % CI) fixed effects |
P | Summary ROR (95 % CI) random effects |
P | I 2 (%) |
---|---|---|---|---|---|---|
Authorship list | ||||||
First/last position | 30 | 1.26 (1.07–1.47) | 0.005 | 1.25 (1.00–1.56) | 0.047 | 35 |
Other position | 20 | 1.53 (1.22–1.92) | 2.5 × 10−4 | 1.58 (1.00–2.47) | 0.048 | 64 |
Continuum level of allegiance | ||||||
Developed and supervised or trained (5) | 6 | 2.22 (1.56–3.17) | 1.2 × 10−5 | 2.39 (1.15–4.99) | 0.020 | 65 |
Developed the therapy (4) | 30 | 1.36 (1.18–1.57) | 3.4 × 10−5 | 1.36 (1.07–1.72) | 0.011 | 49 |
Other (1–3) | 8 | 0.60 (0.38–0.96) | 0.035 | 0.64 (0.31–1.30) | 0.217 | 45 |
Bona fide treatment | ||||||
Yes | 14 | 0.99 (0.79–1.24) | 0.940 | 0.94 (0.68–1.29) | 0.709 | 42 |
No | 10 | 1.68 (1.27–2.22) | 2.8 × 10−4 | 2.51 (1.01–6.23) | 0.048 | 88 |
Unclear | 4 | 1.97 (0.57–6.76) | 0.280 | 1.06 (0.97–1.16) | 0.173 | 0 |
Quality of studies | ||||||
High quality | 15 | 1.28 (1.04–1.50) | 0.021 | 1.54 (0.87–2.74) | 0.141 | 78 |
Moderate quality | 22 | 1.46 (1.12–1.89) | 0.005 | 1.20 (0.73–1.99) | 0.467 | 66 |
Low quality | 7 | 0.41 (0.22–0.77) | 0.041 | 0.53 (0.18–1.58) | 0.257 | 54 |
Treatment integrity assessment | ||||||
Yes | 9 | 1.05 (0.79–1.39) | 0.763 | 0.99 (0.62–1.56) | 0.952 | 53 |
No | 28 | 1.29 (1.07–1.55) | 0.007 | 1.54 (1.01–2.35) | 0.047 | 74 |
Quality of psychotherapy | ||||||
High quality (A) | 6 | 1.01 (0.66–1.55) | 0.973 | 1.48 (0.91–2.42) | 0.120 | 57 |
Unclear quality (B) | 6 | 1.38 (0.84–2.28) | 0.205 | 1.28 (0.49–3.30) | 0.612 | 53 |
Low quality (C) | 27 | 1.28 (1.05–1.56) | 0.014 | 1.61 (1.00–2.59) | 0.049 | 76 |
N number of studies that the comparison under study exists, ROR relative odds ratio